Veracyte Inc
(FRA:12V)
€
39.4
0.8 (2.07%)
Market Cap: 3.16 Bil
Enterprise Value: 2.92 Bil
PE Ratio: 0
PB Ratio: 2.76
GF Score: 81/100 Veracyte Inc at Leerink Partners Global Healthcare Conference Transcript
Mar 01, 2019 / 02:00PM GMT
Release Date Price:
€18.48
(-3.14%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools, Diagnostics, and Senior Research Analyst
Great. So great to have everyone here. I'm Puneet Souda, [covering] tools and diagnostic analyst here. And with me, we have Bonnie Anderson of Veracyte, CEO; and Keith Kennedy. Glad to have you guys -- some new folks who are interested in learning about the story, and then we can jump to the questions right after.
Bonnie H. Anderson
Veracyte, Inc. - Co-Founder, Chairman & CEO
That sounds terrific. Yes, thanks, everyone, and thank you, Leerink, for the conference and for having us here. It's great to be here to give you an update.
Could I have my slides up, please?
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools, Diagnostics, and Senior Research Analyst
Yes, there...
Bonnie H. Anderson
Veracyte, Inc. - Co-Founder, Chairman & CEO
I'll remind everyone, yes, as we get started, of the safe harbor statement and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot